Dendritic Cell Cancer Vaccine Market - Global Outlook and Forecast 2021-2027

Dendritic Cell Cancer Vaccine Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Dendritic Cell Cancer Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dendritic Cell Cancer Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dendritic Cell Cancer Vaccine Overall Market Size
2.1 Global Dendritic Cell Cancer Vaccine Market Size: 2021 VS 2027
2.2 Global Dendritic Cell Cancer Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Dendritic Cell Cancer Vaccine Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Dendritic Cell Cancer Vaccine Players in Global Market
3.2 Top Global Dendritic Cell Cancer Vaccine Companies Ranked by Revenue
3.3 Global Dendritic Cell Cancer Vaccine Revenue by Companies
3.4 Global Dendritic Cell Cancer Vaccine Sales by Companies
3.5 Global Dendritic Cell Cancer Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Dendritic Cell Cancer Vaccine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Dendritic Cell Cancer Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dendritic Cell Cancer Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Dendritic Cell Cancer Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Dendritic Cell Cancer Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Dendritic Cell Cancer Vaccine Market Size Markets, 2021 & 2027
4.1.2 CreaVax
4.1.3 Sipuleucel-T (Provenge)
4.1.4 Others
4.2 By Type - Global Dendritic Cell Cancer Vaccine Revenue & Forecasts
4.2.1 By Type - Global Dendritic Cell Cancer Vaccine Revenue, 2016-2021
4.2.2 By Type - Global Dendritic Cell Cancer Vaccine Revenue, 2022-2027
4.2.3 By Type - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027
4.3 By Type - Global Dendritic Cell Cancer Vaccine Sales & Forecasts
4.3.1 By Type - Global Dendritic Cell Cancer Vaccine Sales, 2016-2021
4.3.2 By Type - Global Dendritic Cell Cancer Vaccine Sales, 2022-2027
4.3.3 By Type - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027
4.4 By Type - Global Dendritic Cell Cancer Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dendritic Cell Cancer Vaccine Market Size, 2021 & 2027
5.1.2 Pediatrics
5.1.3 Adults
5.2 By Application - Global Dendritic Cell Cancer Vaccine Revenue & Forecasts
5.2.1 By Application - Global Dendritic Cell Cancer Vaccine Revenue, 2016-2021
5.2.2 By Application - Global Dendritic Cell Cancer Vaccine Revenue, 2022-2027
5.2.3 By Application - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027
5.3 By Application - Global Dendritic Cell Cancer Vaccine Sales & Forecasts
5.3.1 By Application - Global Dendritic Cell Cancer Vaccine Sales, 2016-2021
5.3.2 By Application - Global Dendritic Cell Cancer Vaccine Sales, 2022-2027
5.3.3 By Application - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027
5.4 By Application - Global Dendritic Cell Cancer Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Dendritic Cell Cancer Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Dendritic Cell Cancer Vaccine Revenue & Forecasts
6.2.1 By Region - Global Dendritic Cell Cancer Vaccine Revenue, 2016-2021
6.2.2 By Region - Global Dendritic Cell Cancer Vaccine Revenue, 2022-2027
6.2.3 By Region - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027
6.3 By Region - Global Dendritic Cell Cancer Vaccine Sales & Forecasts
6.3.1 By Region - Global Dendritic Cell Cancer Vaccine Sales, 2016-2021
6.3.2 By Region - Global Dendritic Cell Cancer Vaccine Sales, 2022-2027
6.3.3 By Region - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Dendritic Cell Cancer Vaccine Revenue, 2016-2027
6.4.2 By Country - North America Dendritic Cell Cancer Vaccine Sales, 2016-2027
6.4.3 US Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.4.4 Canada Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.4.5 Mexico Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Dendritic Cell Cancer Vaccine Revenue, 2016-2027
6.5.2 By Country - Europe Dendritic Cell Cancer Vaccine Sales, 2016-2027
6.5.3 Germany Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.5.4 France Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.5.5 U.K. Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.5.6 Italy Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.5.7 Russia Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.5.8 Nordic Countries Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.5.9 Benelux Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Dendritic Cell Cancer Vaccine Revenue, 2016-2027
6.6.2 By Region - Asia Dendritic Cell Cancer Vaccine Sales, 2016-2027
6.6.3 China Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.6.4 Japan Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.6.5 South Korea Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.6.6 Southeast Asia Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.6.7 India Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Dendritic Cell Cancer Vaccine Revenue, 2016-2027
6.7.2 By Country - South America Dendritic Cell Cancer Vaccine Sales, 2016-2027
6.7.3 Brazil Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.7.4 Argentina Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Sales, 2016-2027
6.8.3 Turkey Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.8.4 Israel Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.8.5 Saudi Arabia Dendritic Cell Cancer Vaccine Market Size, 2016-2027
6.8.6 UAE Dendritic Cell Cancer Vaccine Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Activarti
7.1.1 Activarti Corporate Summary
7.1.2 Activarti Business Overview
7.1.3 Activarti Dendritic Cell Cancer Vaccine Major Product Offerings
7.1.4 Activarti Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.1.5 Activarti Key News
7.2 Argos Therapeutics
7.2.1 Argos Therapeutics Corporate Summary
7.2.2 Argos Therapeutics Business Overview
7.2.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Major Product Offerings
7.2.4 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.2.5 Argos Therapeutics Key News
7.3 SOTIO (Acquired by PPF Group)
7.3.1 SOTIO (Acquired by PPF Group) Corporate Summary
7.3.2 SOTIO (Acquired by PPF Group) Business Overview
7.3.3 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Major Product Offerings
7.3.4 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.3.5 SOTIO (Acquired by PPF Group) Key News
7.4 Bellicum Pharmaceuticals
7.4.1 Bellicum Pharmaceuticals Corporate Summary
7.4.2 Bellicum Pharmaceuticals Business Overview
7.4.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Major Product Offerings
7.4.4 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.4.5 Bellicum Pharmaceuticals Key News
7.5 JW CreaGene
7.5.1 JW CreaGene Corporate Summary
7.5.2 JW CreaGene Business Overview
7.5.3 JW CreaGene Dendritic Cell Cancer Vaccine Major Product Offerings
7.5.4 JW CreaGene Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.5.5 JW CreaGene Key News
7.6 DanDrit
7.6.1 DanDrit Corporate Summary
7.6.2 DanDrit Business Overview
7.6.3 DanDrit Dendritic Cell Cancer Vaccine Major Product Offerings
7.6.4 DanDrit Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.6.5 DanDrit Key News
7.7 DCPrime
7.7.1 DCPrime Corporate Summary
7.7.2 DCPrime Business Overview
7.7.3 DCPrime Dendritic Cell Cancer Vaccine Major Product Offerings
7.4.4 DCPrime Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.7.5 DCPrime Key News
7.8 Elios Therapeutics
7.8.1 Elios Therapeutics Corporate Summary
7.8.2 Elios Therapeutics Business Overview
7.8.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Major Product Offerings
7.8.4 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.8.5 Elios Therapeutics Key News
7.9 ImmunoCellular Therapeutics
7.9.1 ImmunoCellular Therapeutics Corporate Summary
7.9.2 ImmunoCellular Therapeutics Business Overview
7.9.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Major Product Offerings
7.9.4 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.9.5 ImmunoCellular Therapeutics Key News
7.10 Kiromic
7.10.1 Kiromic Corporate Summary
7.10.2 Kiromic Business Overview
7.10.3 Kiromic Dendritic Cell Cancer Vaccine Major Product Offerings
7.10.4 Kiromic Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.10.5 Kiromic Key News
7.11 Medigene
7.11.1 Medigene Corporate Summary
7.11.2 Medigene Dendritic Cell Cancer Vaccine Business Overview
7.11.3 Medigene Dendritic Cell Cancer Vaccine Major Product Offerings
7.11.4 Medigene Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.11.5 Medigene Key News
7.12 Merck
7.12.1 Merck Corporate Summary
7.12.2 Merck Dendritic Cell Cancer Vaccine Business Overview
7.12.3 Merck Dendritic Cell Cancer Vaccine Major Product Offerings
7.12.4 Merck Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.12.5 Merck Key News
7.13 Northwest Biotherapeutics
7.13.1 Northwest Biotherapeutics Corporate Summary
7.13.2 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Business Overview
7.13.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Major Product Offerings
7.13.4 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.13.5 Northwest Biotherapeutics Key News
7.14 Immutep Limited
7.14.1 Immutep Limited Corporate Summary
7.14.2 Immutep Limited Business Overview
7.14.3 Immutep Limited Dendritic Cell Cancer Vaccine Major Product Offerings
7.14.4 Immutep Limited Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.14.5 Immutep Limited Key News
7.15 Dendreon Corporation
7.15.1 Dendreon Corporation Corporate Summary
7.15.2 Dendreon Corporation Business Overview
7.15.3 Dendreon Corporation Dendritic Cell Cancer Vaccine Major Product Offerings
7.15.4 Dendreon Corporation Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.15.5 Dendreon Corporation Key News
7.16 Oncobiomed
7.16.1 Oncobiomed Corporate Summary
7.16.2 Oncobiomed Business Overview
7.16.3 Oncobiomed Dendritic Cell Cancer Vaccine Major Product Offerings
7.16.4 Oncobiomed Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2016-2021)
7.16.5 Oncobiomed Key News
8 Global Dendritic Cell Cancer Vaccine Production Capacity, Analysis
8.1 Global Dendritic Cell Cancer Vaccine Production Capacity, 2016-2027
8.2 Dendritic Cell Cancer Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Dendritic Cell Cancer Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dendritic Cell Cancer Vaccine Supply Chain Analysis
10.1 Dendritic Cell Cancer Vaccine Industry Value Chain
10.2 Dendritic Cell Cancer Vaccine Upstream Market
10.3 Dendritic Cell Cancer Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dendritic Cell Cancer Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Dendritic Cell Cancer Vaccine in Global Market
Table 2. Top Dendritic Cell Cancer Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Dendritic Cell Cancer Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Dendritic Cell Cancer Vaccine Revenue Share by Companies, 2016-2021
Table 5. Global Dendritic Cell Cancer Vaccine Sales by Companies, (K Doses), 2016-2021
Table 6. Global Dendritic Cell Cancer Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Dendritic Cell Cancer Vaccine Price (2016-2021) & (USD/Dose)
Table 8. Global Manufacturers Dendritic Cell Cancer Vaccine Product Type
Table 9. List of Global Tier 1 Dendritic Cell Cancer Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dendritic Cell Cancer Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Dendritic Cell Cancer Vaccine Sales (K Doses), 2016-2021
Table 15. By Type - Global Dendritic Cell Cancer Vaccine Sales (K Doses), 2022-2027
Table 16. By Application - Global Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Dendritic Cell Cancer Vaccine Sales (K Doses), 2016-2021
Table 20. By Application - Global Dendritic Cell Cancer Vaccine Sales (K Doses), 2022-2027
Table 21. By Region - Global Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Dendritic Cell Cancer Vaccine Sales (K Doses), 2016-2021
Table 25. By Region - Global Dendritic Cell Cancer Vaccine Sales (K Doses), 2022-2027
Table 26. By Country - North America Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Dendritic Cell Cancer Vaccine Sales, (K Doses), 2016-2021
Table 29. By Country - North America Dendritic Cell Cancer Vaccine Sales, (K Doses), 2022-2027
Table 30. By Country - Europe Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Dendritic Cell Cancer Vaccine Sales, (K Doses), 2016-2021
Table 33. By Country - Europe Dendritic Cell Cancer Vaccine Sales, (K Doses), 2022-2027
Table 34. By Region - Asia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Dendritic Cell Cancer Vaccine Sales, (K Doses), 2016-2021
Table 37. By Region - Asia Dendritic Cell Cancer Vaccine Sales, (K Doses), 2022-2027
Table 38. By Country - South America Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Dendritic Cell Cancer Vaccine Sales, (K Doses), 2016-2021
Table 41. By Country - South America Dendritic Cell Cancer Vaccine Sales, (K Doses), 2022-2027
Table 42. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Sales, (K Doses), 2016-2021
Table 45. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Sales, (K Doses), 2022-2027
Table 46. Activarti Corporate Summary
Table 47. Activarti Dendritic Cell Cancer Vaccine Product Offerings
Table 48. Activarti Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 49. Argos Therapeutics Corporate Summary
Table 50. Argos Therapeutics Dendritic Cell Cancer Vaccine Product Offerings
Table 51. Argos Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 52. SOTIO (Acquired by PPF Group) Corporate Summary
Table 53. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Product Offerings
Table 54. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 55. Bellicum Pharmaceuticals Corporate Summary
Table 56. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product Offerings
Table 57. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 58. JW CreaGene Corporate Summary
Table 59. JW CreaGene Dendritic Cell Cancer Vaccine Product Offerings
Table 60. JW CreaGene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 61. DanDrit Corporate Summary
Table 62. DanDrit Dendritic Cell Cancer Vaccine Product Offerings
Table 63. DanDrit Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 64. DCPrime Corporate Summary
Table 65. DCPrime Dendritic Cell Cancer Vaccine Product Offerings
Table 66. DCPrime Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 67. Elios Therapeutics Corporate Summary
Table 68. Elios Therapeutics Dendritic Cell Cancer Vaccine Product Offerings
Table 69. Elios Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 70. ImmunoCellular Therapeutics Corporate Summary
Table 71. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Product Offerings
Table 72. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 73. Kiromic Corporate Summary
Table 74. Kiromic Dendritic Cell Cancer Vaccine Product Offerings
Table 75. Kiromic Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 76. Medigene Corporate Summary
Table 77. Medigene Dendritic Cell Cancer Vaccine Product Offerings
Table 78. Medigene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 79. Merck Corporate Summary
Table 80. Merck Dendritic Cell Cancer Vaccine Product Offerings
Table 81. Merck Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 82. Northwest Biotherapeutics Corporate Summary
Table 83. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product Offerings
Table 84. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 85. Immutep Limited Corporate Summary
Table 86. Immutep Limited Dendritic Cell Cancer Vaccine Product Offerings
Table 87. Immutep Limited Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 88. Dendreon Corporation Corporate Summary
Table 89. Dendreon Corporation Dendritic Cell Cancer Vaccine Product Offerings
Table 90. Dendreon Corporation Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 91. Oncobiomed Corporate Summary
Table 92. Oncobiomed Dendritic Cell Cancer Vaccine Product Offerings
Table 93. Oncobiomed Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 94. Dendritic Cell Cancer Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2019-2021 (K Doses)
Table 95. Global Dendritic Cell Cancer Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 96. Global Dendritic Cell Cancer Vaccine Production by Region, 2016-2021 (K Doses)
Table 97. Global Dendritic Cell Cancer Vaccine Production by Region, 2022-2027 (K Doses)
Table 98. Dendritic Cell Cancer Vaccine Market Opportunities & Trends in Global Market
Table 99. Dendritic Cell Cancer Vaccine Market Drivers in Global Market
Table 100. Dendritic Cell Cancer Vaccine Market Restraints in Global Market
Table 101. Dendritic Cell Cancer Vaccine Raw Materials
Table 102. Dendritic Cell Cancer Vaccine Raw Materials Suppliers in Global Market
Table 103. Typical Dendritic Cell Cancer Vaccine Downstream
Table 104. Dendritic Cell Cancer Vaccine Downstream Clients in Global Market
Table 105. Dendritic Cell Cancer Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Dendritic Cell Cancer Vaccine Segment by Type
Figure 2. Dendritic Cell Cancer Vaccine Segment by Application
Figure 3. Global Dendritic Cell Cancer Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Dendritic Cell Cancer Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Dendritic Cell Cancer Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Dendritic Cell Cancer Vaccine Sales in Global Market: 2016-2027 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Dendritic Cell Cancer Vaccine Revenue in 2020
Figure 9. By Type - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027
Figure 10. By Type - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027
Figure 11. By Type - Global Dendritic Cell Cancer Vaccine Price (USD/Dose), 2016-2027
Figure 12. By Application - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027
Figure 13. By Application - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027
Figure 14. By Application - Global Dendritic Cell Cancer Vaccine Price (USD/Dose), 2016-2027
Figure 15. By Region - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027
Figure 16. By Region - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027
Figure 17. By Country - North America Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027
Figure 18. By Country - North America Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027
Figure 19. US Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027
Figure 24. Germany Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 25. France Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027
Figure 33. China Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 37. India Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027
Figure 39. By Country - South America Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027
Figure 40. Brazil Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027
Figure 44. Turkey Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2016-2027
Figure 48. Global Dendritic Cell Cancer Vaccine Production Capacity (K Doses), 2016-2027
Figure 49. The Percentage of Production Dendritic Cell Cancer Vaccine by Region, 2020 VS 2027
Figure 50. Dendritic Cell Cancer Vaccine Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global BCG Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global BCG Vaccine market size was valued at US$ 365.6 million in 2023. With growing demand in downstream market, the BCG Vaccine is forecast to a readjusted size of US$ 542.8 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global BCG Vaccine market. BCG Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Peptide Cancer Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Peptide Cancer Vaccine market size was valued at US$ 535 million in 2023. With growing demand in downstream market, the Peptide Cancer Vaccine is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 20.5% during review period. The research report highlights the growth potential of the global Peptide Cancer Vaccine market. Peptide Cancer Vaccine are expected to show stable growth in the future market. How......

Global Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Vaccine market: According to our latest research, the global Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Cancer Vaccine market was estimated at USD 7198.2 million, and it's anticipated to reach USD 33936.62 million in 2028, with a CAGR of 29.49% during the forecast years. A cancer vaccine is a type of immunotherapy that boost the body's natural defenses by stimulating the immune system to recognize and cur......

Global Lung Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Lung Cancer Vaccines market: According to our latest research, the global Lung Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Lung Cancer Vaccines market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Lung Cancer Vaccines,A cancer vaccine for lung cance This report covers a research time span from 2018 to 2028, and ......

Global Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 105

Market Overview of Global Cancer Vaccines market: According to our latest research, the global Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Cancer Vaccines market was estimated at USD 5773.14 million, and it's anticipated to reach USD 15406.41 million in 2028, with a CAGR of 17.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Vacci......

Global Dendritic Cell Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 110

Market Overview of Global Dendritic Cell Cancer Vaccine market: According to our latest research, the global Dendritic Cell Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Dendritic Cell Cancer Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Dendritic cells (DC) are one of the major antigen presenting cells found in lymphoid organs. The main fu......

Global BCG Vaccine Market Research Report 2023, Forecast to 2028

Published: 14-Nov-2023        Price: US 2680 Onwards        Pages: 135

BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......

Global BCG Vaccine Professional Survey Report 2023, Forecast to 2028

Published: 14-Nov-2023        Price: US 3280 Onwards        Pages: 105

BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......

Infectious Vaccine Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300

Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious vaccine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of infectious vaccine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter infectious vaccine deals. These deals tend to be multicomponent, starting with......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs